Servier, a French pharmaceutical group, has completed its acquisition of the muscular dystrophy business of Edgewise Therapeutics (Nasdaq: EWTX) for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE